X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-17 | LUNG | French Glendon E. III | Dir | S - Sale | $6.52 | -20,000 | 1,091,974 | -2% | -$130,400 | ||||||
2024-09-12 | LUNG | French Glendon E. III | Dir | S - Sale | $8.09 | -20,000 | 1,111,974 | -2% | -$161,800 | ||||||
2024-09-03 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $6.70 | -4,586 | 295,433 | -2% | -$30,721 | ||||||
2024-09-03 | LUNG | Lehman David Aaron | GC | S - Sale | $6.69 | -5,765 | 203,348 | -3% | -$38,576 | ||||||
2024-08-20 | LUNG | Williamson Steven S. | Pres, CEO | P - Purchase | $6.84 | +14,245 | 219,531 | +7% | +$97,436 | ||||||
2024-06-24 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $6.16 | -1,184 | 300,019 | 0% | -$7,293 | ||||||
2024-06-03 | LUNG | Lehman David Aaron | GC | S - Sale | $6.97 | -5,475 | 209,113 | -3% | -$38,161 | ||||||
2024-06-03 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $6.97 | -4,297 | 301,203 | -1% | -$29,950 | ||||||
2024-05-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $8.71 | -1,184 | 305,500 | 0% | -$10,313 | ||||||
2024-04-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $7.49 | -1,184 | 306,684 | 0% | -$8,868 | ||||||
2024-03-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $9.36 | -1,184 | 307,868 | 0% | -$11,082 | ||||||
| D | 2024-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale+OE | $9.06 | -3,097 | 274,452 | -1% | -$28,059 | |||||
| D | 2024-03-01 | LUNG | McKune John | Interim CFO | S - Sale+OE | $9.06 | -1,078 | 61,810 | -2% | -$9,767 | |||||
| D | 2024-03-01 | LUNG | Lehman David Aaron | GC | S - Sale+OE | $9.06 | -4,351 | 179,988 | -2% | -$39,420 | |||||
2024-03-01 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $9.06 | -6,954 | 1,116,758 | -1% | -$63,003 | ||||||
2024-02-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $14.20 | -1,184 | 243,049 | 0% | -$16,813 | ||||||
2024-02-15 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $14.60 | -20,000 | 1,121,344 | -2% | -$292,000 | ||||||
2024-01-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $13.13 | -1,184 | 244,233 | 0% | -$15,546 | ||||||
2024-01-18 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $12.77 | -10,000 | 1,141,344 | -1% | -$127,700 | ||||||
2023-12-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $12.75 | -1,184 | 245,417 | 0% | -$15,096 | ||||||
2023-12-21 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $12.42 | -10,000 | 1,151,344 | -1% | -$124,200 | ||||||
2023-12-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $10.34 | -2,868 | 246,601 | -1% | -$29,655 | ||||||
2023-12-01 | LUNG | McKune John | Interim CFO | S - Sale | $10.34 | -942 | 47,647 | -2% | -$9,739 | ||||||
2023-12-01 | LUNG | Lehman David Aaron | GC | S - Sale | $10.34 | -3,809 | 149,839 | -2% | -$39,381 | ||||||
2023-12-01 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $10.34 | -6,676 | 1,161,344 | -1% | -$69,030 | ||||||
2023-11-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $10.60 | -1,184 | 249,469 | 0% | -$12,550 | ||||||
2023-10-23 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $8.35 | -1,184 | 250,653 | 0% | -$9,886 | ||||||
2023-09-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $10.51 | -1,184 | 251,837 | 0% | -$12,444 | ||||||
2023-09-01 | LUNG | Sung Derrick | CFO | S - Sale | $10.00 | -4,219 | 391,041 | -1% | -$42,201 | ||||||
2023-09-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $10.01 | -2,843 | 253,021 | -1% | -$28,458 | ||||||
2023-09-01 | LUNG | Lehman David Aaron | GC | S - Sale | $10.01 | -3,772 | 153,648 | -2% | -$37,758 | ||||||
2023-09-01 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $10.01 | -6,527 | 1,168,020 | -1% | -$65,335 | ||||||
2023-08-23 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $10.54 | -1,184 | 255,864 | 0% | -$12,479 | ||||||
2023-07-20 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $12.68 | -15,000 | 1,174,547 | -1% | -$190,200 | ||||||
2023-06-15 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $12.68 | -10,000 | 1,189,547 | -1% | -$126,800 | ||||||
2023-06-01 | LUNG | Sung Derrick | CFO | S - Sale | $11.49 | -4,222 | 395,260 | -1% | -$48,507 | ||||||
2023-06-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $11.48 | -2,845 | 257,048 | -1% | -$32,661 | ||||||
2023-06-01 | LUNG | Lehman David Aaron | GC | S - Sale | $11.48 | -3,776 | 157,420 | -2% | -$43,348 | ||||||
2023-06-01 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $11.48 | -6,533 | 1,199,547 | -1% | -$75,009 | ||||||
| D | 2023-03-01 | LUNG | Sung Derrick | CFO | S - Sale+OE | $11.03 | -1,264 | 399,482 | 0% | -$13,942 | |||||
| D | 2023-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale+OE | $11.03 | -1,206 | 259,893 | 0% | -$13,302 | |||||
| D | 2023-03-01 | LUNG | Lehman David Aaron | GC | S - Sale+OE | $11.03 | -1,264 | 161,196 | -1% | -$13,942 | |||||
| D | 2023-03-01 | LUNG | French Glendon E. III | Pres, CEO | S - Sale+OE | $11.03 | -2,895 | 1,206,080 | 0% | -$31,932 | |||||
2022-12-01 | LUNG | French Glendon E. III | Pres, CEO | S - Sale | $5.93 | -3,631 | 1,034,313 | 0% | -$21,532 | ||||||
2022-12-01 | LUNG | Lehman David Aaron | GC | S - Sale | $5.93 | -1,069 | 44,160 | -2% | -$6,339 | ||||||
2022-12-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $5.93 | -1,055 | 181,037 | -1% | -$6,256 | ||||||
2022-12-01 | LUNG | Sung Derrick | CFO | S - Sale | $5.93 | -1,069 | 262,746 | 0% | -$6,339 | ||||||
2022-11-29 | LUNG | Lynch Alissa Hsu | Dir | P - Purchase | $5.51 | +1,700 | 11,910 | +17% | +$9,367 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |